Home Recalls D-507-2013
Class II · Moderate risk Terminated Initiated Jan 30, 2013 (14 years ago)
AMBI 12.5 CPD/120GFN/5PEH, Cough Suppressant, Expectorant, Nasal Decongestant, Berry…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
What was recalled
AMBI 12.5 CPD/120GFN/5PEH, Cough Suppressant, Expectorant, Nasal Decongestant, Berry Vanilla Flavor, 16 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0224-16
Recalling firm TG United, Inc.
NDC code 66870-0224-16
Origin FL, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-507-2013
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Mar 20, 2026
Reason This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Class II · Moderate risk Ongoing Dec 23, 2024
Reason CGMP Deviations; product intended for quarantine was inadvertently distributed
Class II · Moderate risk Terminated Oct 18, 2023
Reason CGMP Deviation: Third party test results showing a presence of acetal and acetaldehyde at levels above USP specified amounts.
Class II · Moderate risk Terminated Oct 4, 2023
Reason CGMP deviations: the product was shipped from the Manufacturer to a Medline warehouse and released to stock while it was still under investigation…
Class I · High risk Completed Jun 18, 2020
Reason Chemical contamination: product contains elevated levels of undeclared lead.